KRO-14512
Kinome_3532; Linsitinib; OSI-906 (Linsitinib); cis-3-[8-amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-1-yl]-1-methylcyclobutan-1-ol; cis-3-(8-amino-1-(2-phenyl-7-quinolinyl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol; OSI-906AA; cis-3-[8-amino-1-(2-phenyl-quinolin-7-yl)-imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutanol; OSI906
867160-71-2
98% min.
scale-up (10-1,000 kg)
C26H23N5O
98% min.
scale-up (10-1,000 kg)
C26H23N5O
KRO-07541
Linifanib; Linifanib (ABT-869); Kinome_532; ABT 869
796967-16-3
98% min.
scale-up (10-1,000 kg)
C21H18FN5O
98% min.
scale-up (10-1,000 kg)
C21H18FN5O
KRO-16805
kro-16805
852808-04-9
98% min.
scale-up (10-1,000 kg)
C42H45ClN6O5S2
98% min.
scale-up (10-1,000 kg)
C42H45ClN6O5S2
KRO-14731
kro-14731
1019779-04-4
98% min.
scale-up (10-1,000 kg)
C20H27Cl3F2N4O
98% min.
scale-up (10-1,000 kg)
C20H27Cl3F2N4O
KRO-15776
Deshydroxy LY-411575; N-[(1S)-2-[[(7S)-6,7-Dihydro-5-methyl-6-oxo-5H-dibenz[b,d]azepin-7-yl]amino]-1-methyl-2-oxoethyl]-3,5-difluorobenzeneacetamide; Dibenzazepine; DBZ
209984-56-5
98% min.
scale-up (10-1,000 kg)
C26H23F2N3O3
98% min.
scale-up (10-1,000 kg)
C26H23F2N3O3
KRO-10202
2-(Ethyl((5-((6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl)amino)isothiazol-3-yl)methyl)amino)-2-methylpropan-1-ol; CS-1341; 2-[Ethyl[[5-[[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-3-isothiazolyl]methyl]amino]-2-methyl-1-propanol
1094069-99-4
98% min.
scale-up (10-1,000 kg)
C20H26N8OS
98% min.
scale-up (10-1,000 kg)
C20H26N8OS
KRO-14619
3mxf; UNII-1MRH0IMX0W; 4flp
1268524-70-4
98% min.
scale-up (10-1,000 kg)
C23H25ClN4O2S
98% min.
scale-up (10-1,000 kg)
C23H25ClN4O2S
KRO-15599
Compound C; BML-275; 6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine; AMPK Inhibitor,Compound C
866405-64-3
98% min.
scale-up (10-1,000 kg)
C24H25N5O
98% min.
scale-up (10-1,000 kg)
C24H25N5O
KRO-11667
X6K; PI103
371935-74-9
98% min.
scale-up (10-1,000 kg)
C19H17ClN4O3
98% min.
scale-up (10-1,000 kg)
C19H17ClN4O3
KRO-10204
Lopac-S-2064; 5-(4-Chlorophenyl)-1-(4-methoxyphenyl)-3-trifluoromethyl pyrazole; Ionomycin calcium salt; SC560
188817-13-2
98% min.
scale-up (10-1,000 kg)
C17H12ClF3N2O
98% min.
scale-up (10-1,000 kg)
C17H12ClF3N2O
KRO-49789
5H-DIBENZ(b,f)AZEPINE-5-CARBOXAMIDE,10,11-DIHYDRO; 10,11-Dihydro-5H-dibenzo[b,f]azepine-5-carboxamide; 10,11-Dihydro-5H-dibenz[b,f]azepine-5-carboxamide; 10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide; 10,11-Dihydrocarbamazepine; 10,11-Dihydro-5-carbamoyl-5H-dibenz<b,f>azepine; EINECS 222-649-0; 10,11-Dihydro-5H-dibenz(b,f)azepine-5-carboxamide; 10,11-Dihydrocarbamazepine,10,11-Dihydro-5H-dibenz[b,f]azepine-5-carboxamide; GP 26-301; 10,11-Dihydro-5-carbamoyl-5H-dibenz<b,f>azepin; 10,11-dihydro-5-carboxamido-5H-dibenz<b,f>azepine; 10,11-DIHYDROCARBAMAZEPINE
3564-73-6
98% min.
scale-up (10-1,000 kg)
C15H14N2O
98% min.
scale-up (10-1,000 kg)
C15H14N2O
KRO-05177
3-(2-(Imidazo[1,2-b]pyridazin-3-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide; Iclusig; PONATINIB; 3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide; 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide
943319-70-8
98% min.
scale-up (10-1,000 kg)
C29H27F3N6O
98% min.
scale-up (10-1,000 kg)
C29H27F3N6O
KRO-17714
7-(2-phenylethyl)-5-amino-2-(2-furyl)-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine; 2-(Furan-2-yl)-7-phenethyl-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine
160098-96-4
98% min.
scale-up (10-1,000 kg)
C18H15N7O
98% min.
scale-up (10-1,000 kg)
C18H15N7O
KRO-14621
N-(4-ethoxyphenyl)-4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-thiazolamine; N-(4-Ethoxyphenyl)-4-(2-methylimidazo[1,2-a]pyridin-3-yl)thiazol-2-amine; HH SIGNALING ANTAGONIST VII
315703-52-7
98% min.
scale-up (10-1,000 kg)
C19H18N4OS
98% min.
scale-up (10-1,000 kg)
C19H18N4OS
KRO-44523
2-(3,4-dichlorophenyl)-1-[2-(pyrrolidin-1-ylmethyl)piperidin-1-yl]ethanone,hydrochloride
130497-33-5
98% min.
scale-up (10-1,000 kg)
C18H25Cl3N2O
98% min.
scale-up (10-1,000 kg)
C18H25Cl3N2O
KRO-21725
IAP TRIFLUOROACETATE; IAP TFA
213764-92-2
98% min.
scale-up (10-1,000 kg)
C9H13Cl2IN2O
98% min.
scale-up (10-1,000 kg)
C9H13Cl2IN2O
KRO-14482
kro-14482
186544-26-3
98% min.
scale-up (10-1,000 kg)
C21H22FN3O
98% min.
scale-up (10-1,000 kg)
C21H22FN3O
KRO-14483
LY-310,762 hydrochloride
192927-92-7
98% min.
scale-up (10-1,000 kg)
C24H28ClFN2O2
98% min.
scale-up (10-1,000 kg)
C24H28ClFN2O2
KRO-48908
2-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)-isoindoline-1,3-dione hydrobromide; 2-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)isoindoline-1,3-dione hydrobromide
115388-32-4
98% min.
scale-up (10-1,000 kg)
C23H28BrN3O3
98% min.
scale-up (10-1,000 kg)
C23H28BrN3O3
KRO-17253
8-[2-[4-(2-Methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione dihydrochloride; BMY 7378 dihydrochloride
21102-95-4
98% min.
scale-up (10-1,000 kg)
C22H33Cl2N3O3
98% min.
scale-up (10-1,000 kg)
C22H33Cl2N3O3